AbbVie Joins Obesity Treatment Market With Up to $2.2B Licensing Deal – Investopedia
… Zepbound, which involve the hormone GLP-1. Shares of AbbVie gained more … Zepbound injection …
Biotech’s top money raisers: 2024
… GLP-1 drugs—including an injectable GLP-1/GIP receptor dual agonist and an oral small-molecule GLP-1 receptor agonist, both clinical-stage …
GLP-1 Drugs Offer More Than Weight Loss and Glucose Control – Medscape
Dr Priya Jaisinghani discusses the benefits of GLP-1 therapy beyond glycemic control and weight management.
Conagra ‘GLP-1 Friendly’ Badge Taps the Weight Loss Drug Craze – Packaging Digest
Select Healthy Choice frozen meal packages get a makeover with an “On Target” nutritional badge to target the 15.5 million US adults taking GLP-1 …
Opinion: Are discount diet drugs safe? No one knows | The River Reporter
… compounded GLP-1 weight-loss drugs that are cheaper than the authentic prescription versions like Zepbound and Ozempic. These ads …
Emergency Medicine Faculty Member Helping NASA to Solve the Problems of Medical Care …
… CU Researcher Studying Effects of GLP-1 Drugs on Alcohol Addiction. by Greg Glasgow | Feb 7, 2025 …
GLP-1 Receptor Agonist Use Not Linked to Increased Suicide Risk – Drugs.com MedNews
Glucagon-like peptide-1 (GLP-1) receptor agonists are not associated with an increased risk for suicidality compared with dipeptidyl peptidase-4 …
Trouble sleeping? The culprit may be something you ate – American Heart Association
Among women, it altered levels of GLP-1, reducing satiety, meaning women felt less full after eating. So what foods should people eat if they want …
Hims & Hers Stock Dip and What It Means for Telehealth and Clinicians
… semaglutide shortage had been resolved. Semaglutide is the active ingredient in weight loss meds like Ozempic and Wegovy, and compounding is legal …
AbbVie gets into obesity with $350M deal for once-weekly shot | BioPharma Dive
If successful, these drugs could be used as alternatives to or in combination with marketed drugs like Novo’s Wegovy and Lilly’s Zepbound to increase …